| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36,9 k € | -55.4% | 82,6 k € | +12.6% | 73,3 k € | -37.4% | 117,2 k € | -12.7% | 134,3 k € | -0.9% | 135,5 k € | +26.7% | 106,9 k € | +47.2% | 72,6 k € | -31.5% | 106,1 k € | +4.8% | 101,2 k € | +39.7% | 72,4 k € | |
| Gross margin | 15,0 k € | -74.6% | 59,0 k € | +53.6% | 38,4 k € | -54.7% | 84,8 k € | +3.8% | 81,7 k € | -13.2% | 94,1 k € | +45.3% | 64,8 k € | +93.5% | 33,5 k € | -53.2% | 71,5 k € | +0.4% | 71,3 k € | +64.4% | 43,3 k € | |
| EBITDA | 13,3 k € | -76.9% | 57,6 k € | +55.4% | 37,0 k € | -55.0% | 82,3 k € | +2.8% | 80,1 k € | -13.3% | 92,3 k € | +46.8% | 62,9 k € | +98.4% | 31,7 k € | -54.6% | 69,8 k € | +1.3% | 68,9 k € | +63.2% | 42,2 k € | |
| Operating profit | 1,4 k € | -96.8% | 43,1 k € | +93.6% | 22,3 k € | -67.6% | 68,8 k € | -0.3% | 69,1 k € | -12.7% | 79,1 k € | +61.1% | 49,1 k € | +168.7% | 18,3 k € | -67.8% | 56,8 k € | +0.8% | 56,3 k € | +60.0% | 35,2 k € | |
| Profit/loss | 3,3 k € | -88.9% | 29,6 k € | +140.7% | 12,3 k € | -72.2% | 44,3 k € | -0.1% | 44,3 k € | -17.2% | 53,6 k € | +90.9% | 28,1 k € | +84.3% | 15,2 k € | -56.5% | 35,0 k € | +1.3% | 34,6 k € | +33.6% | 25,9 k € | |
| Equity | 221,0 k € | +1.1% | 218,5 k € | +15.2% | 189,7 k € | +6.5% | 178,2 k € | +32.3% | 134,7 k € | +48.0% | 91,0 k € | -41.5% | 155,5 k € | +21.4% | 128,0 k € | +12.2% | 114,1 k € | +44.3% | 79,1 k € | +77.8% | 44,5 k € | |
| Total assets | 253,2 k € | -1.6% | 257,3 k € | +12.0% | 229,8 k € | +2.1% | 225,0 k € | +12.8% | 199,5 k € | -28.1% | 277,5 k € | +21.4% | 228,5 k € | +13.6% | 201,2 k € | +1.2% | 198,7 k € | +27.3% | 156,1 k € | +21.7% | 128,2 k € | |
| Cash | 64,7 k € | -36.1% | 101,3 k € | +29.4% | 78,3 k € | +22.3% | 64,0 k € | +54.6% | 41,4 k € | -75.6% | 169,6 k € | +88.1% | 90,1 k € | +76.3% | 51,1 k € | +23.1% | 41,5 k € | +11.0% | 37,4 k € | +19.9% | 31,2 k € | |
| Debts | 32,2 k € | -17.0% | 38,8 k € | -3.1% | 40,1 k € | -14.3% | 46,8 k € | -27.8% | 64,8 k € | -65.2% | 186,5 k € | +155.3% | 73,1 k € | -0.1% | 73,2 k € | -13.6% | 84,6 k € | +9.9% | 77,0 k € | -8.0% | 83,7 k € | |
Private limited company · Liège · incorporated on 08/10/2014
Private limited company profitable and well capitalised. Cash position declining (-36.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CABINET DE RHUMATOLOGIE ET MEDECINE D'EXPERTISE DR. C. RIBBENS is a Private limited company incorporated in 2014. Its main activity is: Technical testing and analysis. Its registered office is in Liège.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette